Prader-Willi syndrome: An update and review for the primary pediatrician

Clinical Pediatrics

Volumn 46, Issue 7, 2007, Pages 580-591

  Chen, Christina ^a   Visootsak, Jeannie ^a,c   Dills, Shelley ^a   Graham Jr , John M ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c David Geffen School of Medicine at UCLA ^*  (United States)

Author keywords

Developmental delay; Growth hormone; Hypotonia; Obesity; Prader Willi syndrome

Indexed keywords

FLUOXETINE; GLYCINE DEHYDROGENASE (DECARBOXYLATING); GROWTH HORMONE; RIBONUCLEOPROTEIN; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE; ZINC FINGER PROTEIN;

AUTISM; BEHAVIOR DISORDER; CHILD; CHROMOSOME 15; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DIET; DRUG DOSE INCREASE; EARLY INTERVENTION; FAILURE TO THRIVE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETIC DISORDER; GENOME IMPRINTING; HUMAN; HYPERPHAGIA; HYPOGONADISM; INCIDENCE; KYPHOSIS; LOW DRUG DOSE; MALADJUSTMENT; MENTAL DEFICIENCY; MUSCLE HYPOTONIA; OBESITY; OBSESSIVE COMPULSIVE DISORDER; OCCUPATIONAL THERAPY; PHYSICIAN; PHYSIOTHERAPY; PRADER WILLI SYNDROME; PREVALENCE; PSYCHOSIS; RECOMMENDED DRUG DOSE; REFLEX DISORDER; RESPIRATORY TRACT DISEASE; REVIEW; SCOLIOSIS; SHORT STATURE; SPEECH THERAPY; STRABISMUS; TOOTH MALFORMATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PRADER-WILLI SYNDROME;

EID: 34547594864     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922807299314     Document Type: Review

References (95)

1. Clarke DJ, Boer H. Genetic and behavioural aspects of Prader-Willi syndrome: a review with a translation of the original paper. Ment Handicap Res. 1995 ; 8: 38-53.
2. Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenen SB, Crawford JD Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med. 1981 ; 304: 325-329.
3. Hawkey CJ, Smithies A. The Prader-Willi syndrome with a 15/15 translocation: case report and review of the literature. J Med Genet. 1976 ; 13: 152-156.
4. Knoll Jhm, Nichols RD, Magenis RE, Graham JM Jr, Lalande M., Latt SA Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Genet. 1989 ; 32: 285-290.
5. Driscoll DJ, Waters MF, Williams CA, et al. A DNA methylation imprint, determined by the sex of the parent, distinguishes the Angelman and the Prader-Willi syndromes. Genomics. 1992 ; 13: 917-924.
6. Nicholls RD Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndrome: a review. Am J Med Genet. 1993 ; 46: 16-25.
7. Nicholls RD, Knoll Jhm, Butler MG, Karam S., Lalande M. Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader-Willi syndrome. Nature. 1989 ; 342: 281-285.
8. Robinson WP, Bottani A., Yagang X., et al. Molecular, cytogenetic and clinical investigations of Prader-Willi syndrome patients. Am J Hum Genet. 1991 ; 49: 1219-1234.
9. Robinson WP, Bottani A., Xie YG, et al. The frequency of uniparental disomy in Prader-Willi syndrome. N Engl J Med. 1992 ; 326: 1599-1607.
10. Cassidy SB, Lai LW, Erickson RP, et al. Trisomy 15 with loss of the paternal 15 as a cause of Prader-Willi syndrome due to maternal disomy. Am J Hum Genet. 1992 ; 51: 701-708.
11. Buiting K., Saitoh S., Gross S., et al. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat Genet. 1994 ; 9: 395-400.
12. Saitoh S., Buiting K., Cassidy SB, et al. Clinical spectrum and molecular diagnosis of Angelman and Prader-Willi syndrome imprinting mutation patients. Am J Med Genet. 1997 ; 68: 195-206.
13. Buiting K., Gross S., Lich C., Gillessen-Kaesbach G., el-Maarri O., Horsthemke B. Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. Am J Hum Genet. 2003 ; 72: 571-577.
14. Clayton-Smith J., Pembrey ME Angelman syndrome. J Med Genet. 1992 ; 29: 412-415.
15. Williams CA, Angelman H., Clayton-Smith J., et al. Angelman syndrome: consensus for diagnostic criteria. Am J Med Genet. 1995 ; 56: 237-238.
16. Malzac P., Webber H., Moncla A., et al. Mutation analysis of UBE3A in Angelman syndrome patients. Am J Hum Genet. 1998 ; 62: 1353-1360.
17. Fang P., Lev-Lehman E., Tsai TF, et al. The spectrum of mutations in UBE3A causing Angelman syndrome. Hum Mol Genet. 1999 ; 8: 129-135.
18. Khan NL, Wood NW Prader-Willi and Angelman syndromes: update on genetic mechanisms and diagnostic complexities. Curr Opin Neurol. 1999 ; 12: 149-154.
19. Ozcelik T., Leff S., Robinson W., et al. Small nuclear ribonucleoprotein polypeptide N (SNRPN), and expressed gene in the Prader-Willi syndrome critical region. Nat Genet. 1992 ; 2: 265-269.
20. Glenn CC, Porter KA, Jong Mtc, Nicholls RD, Driscoll DJ Functional imprinting and epigenetic modification of the human SNRPN gene. Hum Mol Genet. 1993 ; 2: 2001-2005.
21. Glenn CC, Saitoh S., Jong Mtc, et al. Gene structure, DNA methylation and imprinted expression of the human SNRPN gene. Am J Hum Genet. 1996 ; 58: 335-346.
22. Jay P., Rougeulle C., Massacrier A., et al. The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nat Genet. 1997 ; 17: 357-361.
23. Spritz RA, Bailin T., Nicholls RD, et al. Hypopigmentation in the Prader-Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allele. Am J Hum Genet. 1997 ; 71: 57-62.
24. Cassidy SB, Forsythe M., Heeger S., et al. Comparison of phenotype between patients with Prader-Willi syndrome due to deletion 15q and uniparental disomy 15. Am J Med Genet. 1997 ; 68: 433-440.
25. Gillessen-Kaesbach G., Robinson W., Lohmann D., Kaya-Westerloh S., Passarge E., Horsthemke B. Genotype-phenotype correlation in a series of 167 deletion and non-deletion patients with Prader-Willi syndrome. Hum Genet. 1995 ; 96: 638-643.
26. Dykens EM Are jigsaw puzzle skills "spared " in persons with Prader-Willi syndrome? J Child Psychol Psychiatry. 2002 ; 43: 343-352.
27. Dykens EM, Cassidy SB, King BH Maladaptive behavior differences in Prader-Willi syndrome due to paternal deletion versus maternal uniparental disomy. Am J Ment Retard. 1999 ; 104: 67-77.
28. Roof E., Stone W., MacLean W, Feurer ID, Thompson T, Butler MG. Intellectual characteristics of Prader-Willi syndrome: comparison of genetic subtypes. J Intellect Disabil Res. 2000 ; 44: 25-30.
29. Gunay-Aygun M., Cassidy SB Delayed diagnosis in Prader-Willi syndrome due to uniparental disomy. Am J Med Genet. 1997 ; 71: 106-110.
30. Holland AJ, Whittington JE, Butler J., Webb T., Boer H., Clarke D. Behavioural phenotypes associated with specific genetic disorders: evidence from a population-based study of people with Prader-Willi syndrome. Psychol Med. 2003 ; 33: 141-153.
31. Veltman MW, Thompson RJ, Roberts SE, Thomas NS, Whittington J., Bolton PF Prader-Willi syndrome-a study comparing deletion and uniparental disomy cases with reference to autism spectrum disorders. Eur Child Adolesc Psychiatry. 2004 ; 13: 42-50.
32. Whittington J., Holland A., Webb T., Butler J., Clarke D., Boer H. Cognitive abilities and genotype in a population-based sample of people with Prader-Willi syndrome. J Intellect Disabil Res. 2004 ; 48: 172-187.
33. Hudgins L., Geer JS, Cassidy SB Phenotypic differences in African-Americans with Prader-Willi syndrome. Genet Med. 1998 ; 1: 49-51.
34. Cassidy SB, Geer JS, Holm VA, Hudgins L. African-Americans with Prader-Willi syndrome are phenotypically different. Am J Hum Genet. 1996 ; 59: A21.
35. Whittington JE, Holland AJ, Webb T., Butler J., Webb T., Clarke D. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet. 2001 ; 38: 792-798.
36. Butler JV, Whittington JE, Holland AJ, Boer H., Clarke D., Webb T. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol. 2002 ; 44: 248-255.
37. Smith A., Egan J., Ridley G., et al. Birth prevalence of Prader-Willi syndrome in Australia. Arch Dis Child. 2003 ; 88: 263-264.
38. Vogels A., Van Den Ende J., Keymolen K., et al. Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders. Eur J Hum Genet. 2004 ; 12: 238-240.
39. Cassidy SB, McCandless SE Prader-Willi syndrome. In: Cassidy SB, Allanson JE, eds. Management of Genetic Syndromes. 2 nd ed. Hoboken, NJ: John Wiley & Sons, 2005: 429-448.
40. Schrander-Stumpel CT, Curfs L., Sastrowijoto P., Cassidy SB, Schrander JU, Fryns JP Prader-Willi syndrome: causes of death in an international series of cases. Am J Med Genet. 2004 ; 124A: 333-338.
41. Stevenson DA, Anaya TM, Clayton-Smith J., et al. Unexpected death and critical illness in Prader-Willi syndrome: report of ten individuals. Am J Med Genet. 2004 ; 124A: 154-164.
42. Toth-Fejel S., Magenis RE, Leff S., et al. Prenatal diagnosis of chromosome 15 abnormalities in the Prader-Willi/ Angelman syndrome region by traditional and molecular cytogenetics. Am J Med Genet. 1995 ; 55: 444-452.
43. Fong BF, De Vries JI. Obstetric aspects of the Prader-Willi syndrome. Ultrasound Obstet Gynecol. 2003 ; 21: 389-392.
44. Holm VA, Cassidy SB, Butler M., et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993 ; 91: 398-402.
45. Gunay-Aygun M., Schwartz S., Heeger S., O'Riordan MA, Cassidy SB The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics. 2001 ; 108: E92.
46. Dykens EM, Cassidy SB Prader-Willi syndrome: genetic, behavioral and treatment issues. Child Adolesc Psychiatr Clin North Am. 1996 ; 5: 913-927.
47. Aughton DJ and Cassidy SB Physical features of Prader-Willi syndrome in neonates. Am J Dis Child. 1990 ; 144: 1351-1254.
48. Crino A., Schiaffini R., Ciampalini P., et al. Hypogonadism and pubertal development in Prader-Willi syndrome. Eur J Pediatr. 2003 ; 162: 327-33.
49. Monaghan KG, Wiktor A., Van Dyke DL Diagnostic testing for Prader-Willi syndrome and Angelman syndrome: a cost comparison. Genet Med. 2002 ; 4: 448-450.
50. Gunay-Aygun M., Cassidy SB, Nicholls RD Prader-Willi and other syndromes associated with obesity and mental retardation. Behav Genet. 1997 ; 27: 307-324.
51. DiMario FJ Jr, Dunham B., Burleson JA, Moskovitz J., Cassidy SB An evaluation of autonomic nervous system function in patients with Prader-Willi syndrome. Pediatrics. 1994 ; 93: 76-81.
52. Wiesner GL, Bendel CM, Olds DP, et al. Hypopigmentation in the Prader-Willi syndrome. Am J Med Genet. 1987 ; 40: 431-442.
53. Butler MG Hypopigmentation: a common feature of the Prader-Labhart-Willi syndrome. Am J Hum Genet. 1989 ; 45: 140-146.
54. Creel DJ, Bendel CM, Wiesner GL, Wirtschafter JD, Arthur DC, King RA Abnormalities of the central visual pathways in Prader-Willi syndrome associated with hypopigmentation. N Engl J Med. 1986 ; 314: 1606-1609.
55. Lee Pdk. Endocrine and metabolic aspects of Prader-Willi syndrome. In: Louise Greenswag L, Alexander R, eds. Management of Prader-Willi Syndrome. New York, NY: Springer-Verlag, 1995: 32-57.
56. Angulo M., Castro-Magana M., Mazur B., Canas JA, Vitollo PM, Sarrantonio M. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab. 1996 ; 9: 393-400.
57. Butler MG, Meaney FJ Standards for selected anthropometric measurements in Prader-Willi syndrome. Pediatrics. 1991 ; 88: 853-860.
58. West LA, Ballock RT High incidence of hip dysplasia but not slipped capital femoral epiphysis in patients with Prader-Willi syndrome. J Pediatr Orthop. 2004 ; 24: 565-567.
59. Butler MG, Haber L., Mernaugh R., Carlson MG, Price R., Feurer ID Decreased bone mineral density in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet. 2001 ; 103: 216-222.
60. Hoybye C., Hilding A., Jacobsson H., Thoren M. Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity. J Clin Endocrinol Metab. 2002 ; 87: 3590-3597.
61. Zipf WB, Bernston GG Characteristics of abnormal food-intake patterns in children with Prader-Willi syndrome and study of effects of naloxone. Am J Clin Nutr. 1987 ; 46: 277-281.
62. Holland AJ, Treasure J., Coskeran P., Dallow J., Milton N., Hillhouse E. Measurement of excessive appetite and metabolic changes in Prader-Willi syndrome. Int J Obes. 1993 ; 17: 526-532.
63. Butler MG, Bittel lDC, Talebizadeh Z. Plasma peptide YY and ghrelin levels in infants and children with Prader-Willi syndrome. J Pediatr Endocrinol Metab. 2004 ; 17: 1177-1184.
64. Holm VA, Pipes PL Food and children with Prader-Willi syndrome. Am J Dis Child. 1976 ; 130: 1063-1067.
65. Butler MG, Butler RI, Meaney FJ The use of skinfold measurements to judge obesity during the early phase of Prader-Labhart-Willi syndrome. Int J Obes. 1988 ; 12: 417-422.
66. Akefeldt A., Tornhage CJ, Gillberg C. " A woman with Prader-Willi syndrome gives birth to a healthy baby girl" [letter]. Dev Med Child Neurol. 1999 ; 41: 789-790.
67. Schulze A., Mogensen H., Hamborg-Petersen B., et al. Fertility in Prader-Willi syndrome: a case report with Angelman syndrome in the offspring. Acta Paediatr. 2001 ; 90: 455-459.
68. Butler JV, Whittington JE, Holland AJ, Boer H., Clarke D., Webb T. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol. 2002 ; 44: 248-255.
69. Lewis BA Speech and language disorders associated with Prader-Willi syndrome. In: Butler MG, Lee PDK, Whitman BY, eds. Management of Prader-Willi Syndrome. 3 rd ed. New York, NY: Springer-Verlag ; 2006: 272-283.
70. Dykens EM, Hodapp RM, Walsh K., Nash L. Profiles, correlates and trajectories of intelligence in individuals with Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry. 1992 ; 31: 1125-1130.
71. Curfs LG Psychological profile and behavioral characteristics in Prader-Willi syndrome. In: Cassidy SB, ed. Prader-Willi Syndrome and Other 15q Deletion Disorders. Berlin, Germany: Springer-Verlag, 1992: 211-222.
72. Whittington J., Holland A., Webb T., Butler J., Clarke D., Boer H. Academic underachievement by people with Prader-Willi syndrome. J Intellect Disabil Res. 2004 ; 48: 188-200.
73. Greenswag L., Alexander R. Early diagnosis in Prader-Willi syndrome: implications for managing weight and behavior. Dysmorphol Clin Genet. 1990 ; 4: 8-12.
74. Greenswag LR Adults with Prader-Willi syndrome. A survery of 232 cases. Dev Med Child Neurol. 1987 ; 29: 145-152.
75. Waters J. Prader-Willi syndrome. In: Profound Mental Retardation and Multiple Impairment, Vol 3: Medical and Physical Care and Management. London, UK: Chapman and Hall ; 1990.
76. Steinhausen HC, Eiholzer U., Hauffa BP, Malin Z. Behavioural and emotional disturbances in people with Prader-Willi Syndrome. J Intellect Disabil Res. 2004 ; 48: 47-52.
77. Dykens EM, Cassidy SB Correlates of maladaptive behavior in children and adults with Prader-Willi syndrome. Am J Med Genet. 1995 ; 60: 546-549.
78. Dykens EM, Leckman JF, Cassidy SB Obsessions and compulsions in Prader-Willi syndrome. J Child Psychol Psychiatry. 1996 ; 37: 995-1002.
79. Boer H., Holland A., Whittington J., Butler J., Webb T., Clarke D. Psychotic illness in people with Prader-Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet. 2002 ; 359: 135-136.
80. Nixon GM, Brouillette RT Sleep and breathing in Prader-Willi syndrome. Pediatr Pulmonol. 2002 ; 34: 209-217.
81. Hertz G., Cataletto M., Feinsilver SH, Angulo M. Developmental trends of sleep-disordered breathing in Prader-Willi syndrome: the role of obesity. Am J Med Genet. 1995 ; 56: 188-190.
82. Carrel AL, Lee Pdk, Mogul HR Growth hormone and Prader-Willi syndrome. In: Butler MG, Lee PDK, Whitman BY, eds. Management of Prader-Willi Syndrome. 3 rd ed. New York, NY: Springer-Verlag ; 2006: 201-244.
83. Eiholzer U., Schlumpf M., Nordmann Y., l'Allemand D. Early manifestations of Prader-Willi syndrome: influence of growth hormone. J Pediatr Endocrinol Metab. 2001 ; 14: 1441-1444.
84. Hoybye C., Hilding A., Jacobsson H., Thoren M. Growth hormone treatment improves body composition in adults with Prader-Willi syndrome. Clin Endocrinol. 2003 ; 58: 653-661.
85. Carrel AL, Myers SE, Whitman BY, Allen DB Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent. J Pediatr Endocrinol Metab. 2001 ; 14: 1097-1105.
86. Carrel AL, Myers SE, Whitman BY, Allen DB Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab. 2002 ; 87: 1582-1585.
87. Nordmann Y., Eiholzer U., l'Allemand D., Mirjanic S., Markwalder C. Sudden death of an infant with Prader-Willi syndrome-not a unique case? Biol Neonate. 2002 ; 82: 139-142.
88. Eiholzer U., Nordmann Y., l'Allemand D. Fatal outcome of sleep apnoea in PWS during the initial phase of growth hormone treatment. A case report. Horm Res. 2002 ; 58: 24-26.
89. Vliet GV, Deal CL, Crock PA, Robitaille Y., Oligny LL Sudden death in growth hormone-treated children with Prader-Willi syndrome. J Pediatr. 2004 ; 144: 129-131.
90. Burman P., Ritzen EM, Lindgren AC Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev. 2001 ; 22: 787-799.
91. Brice JA Behavioral and psychotropic interventions in persons with Prader-Willi syndrome. Endocrinologist. 2000 ; 10: 27S - 30S.
92. Benjamin E., Buot-Smith T. Naltrexone and fluoxetine in Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry. 1993 ; 32: 870-873.
93. Desh B., Budow L. The use of fluoxetine in an adolescent with Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry. 1991 ; 30: 298-302.
94. Durst R., Rubin-Jobotinsky K., Raskin S., Katz G., Zislin J. Risperidone in treating behavioural disturbances of Prader-Willi syndrome. Acta Psychiatr Scand. 2000 ; 102: 461-465.
95. Cassidy SB, Devi A., Mukaida C. Aging in Prader-Willi syndrome: 232 patients over age 30 years. Proc Greenwood Genet Center. 1994 ; 13: 102-103.